Buy with caution: Are there generic versions of serputinib/serpatinib?

The original drug Selpercatinib (Selpercatinib) is currently marketed and sold in many overseas countries. It is a drug for the treatment of certain mutations of non-small cell lung cancer (NSCLC), medullary thyroid cancer (MTC) and thyroid cancer. It is understood that generic drugs of Seputinib are currently produced and sold. Its pharmaceutical ingredients are basically the same as those of the original drug. There may be slight differences in production specifications and prices. Common manufacturers of generic drugs include Everest Pharmaceutical Factory in Bangladesh, Lucius Pharmaceutical Factory in Laos, etc.

Seputinib is a cancer drug used in people whose cancer is caused by changes in a gene called RET. It can be used specifically for adults with advanced non-small cell lung cancer who have not been treated with RET inhibitors; adults with advanced thyroid cancer who have been treated with the cancer drugs sorafenib or lenvatinib, or both; and advanced medullary thyroid cancer in patients over 12 years old. Selpercatinibcontains the active substance selpercatinib.

Up to now, the original research drug is sold in China under the name of Seputinib, but it is not included in medical insurance. The price of each box of 80mg*56 tablets may be more than 10,000 yuan. There are European and American versions of the original drugs sold overseas, with the price of each box ranging from 20,000 to more than 100,000 yuan (prices may fluctuate due to exchange rates). The generic version of Septinib produced by Lucius Pharmaceutical Factory in Laos and sold overseas is priced at more than RMB 4,000 per box (specification: 40mg*120 capsules) (the price may fluctuate due to exchange rates). For more overseas drug information and specific prices, please consult Yaode Medical Consultant.